Aethlon Medical, Inc.
General ticker "AEMD" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $3.2M (TTM average)
Aethlon Medical, Inc. does not follow the US Stock Market performance with the rate: -25.4%.
Estimated limits based on current volatility of -17.7%: low 5.04$, high 5.38$
Factors to consider:
- Total employees count: 9 (0.0%) as of 2026
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Going concern doubt, Liquidity and credit risks, Product development failure, Labor/talent shortage/retention, Manufacturing cost control
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2026-03-31 to 2028-03-30
- 2026-03-31 to 2027-03-31 estimated range: [4.29$, 17.97$]
- 2027-03-31 to 2028-03-30 estimated range: [2.12$, 8.95$]
Financial Metrics affecting the AEMD estimates:
- Negative: with PPE of -0.2 at the end of fiscal year the price was high
- Negative: negative Operating income
- Negative: negative Operating cash flow
- Negative: negative Industry operating cash flow (median)
- Negative: negative Net income
- Negative: 69.38 < Shareholder equity ratio, % of 77.15 <= 81.92
- Negative: Investing cash flow per share per price, % of -49863.73 <= -40.59
- Negative: 0.07 < Interest expense per share per price, % of 0.19
- Negative: 0.47 < Industry inventory ratio change (median), % of 0.90
Short-term AEMD quotes
Long-term AEMD plot with estimates
Financial data
| YTD | 2024-03-31 | 2025-03-31 | 2026-03-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $12.64MM | $9.34MM | $7.29MM |
| Operating Income | $-12.64MM | $-9.34MM | $-7.29MM |
| Non-Operating Income | $0.43MM | $-4.05MM | $0.14MM |
| Interest Expense | $0.00MM | $0.01MM | $0.01MM |
| R&D Expense | $0.00MM | $0.00MM | $1.91MM |
| Income(Loss) | $-12.21MM | $-13.39MM | $-7.15MM |
| Net Income(Loss)* | $-12.21MM | $-13.39MM | $-7.15MM |
| Stockholders Equity | $5.77MM | $5.12MM | $4.89MM |
| Assets | $8.25MM | $7.36MM | $6.33MM |
| Operating Cash Flow | $-10.13MM | $-7.65MM | $-7.00MM |
| Capital expenditure | $0.25MM | $0.00MM | $0.00MM |
| Investing Cash Flow | $-0.25MM | $0.00MM | $-0.00MM |
| Financing Cash Flow | $1.29MM | $7.73MM | $6.52MM |
| Earnings Per Share** | $-393.81 | $-85.82 | $-10.63 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.